Wayne A.I. Frederick sold $502k of PODD
director at INSULET CORP. 1,825 shares at an average of $275.00, traded Mar 25, 2025, filed Mar 26, 2025.
Score components
- +15RoleDirector
- +18Trade size$502k at market
- +10Share of holdings soldSold 36% of holdings
- 0ClusterNo other insider selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001127602-25-010481, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 25, 2025 | SOpen-market sale Common Stock10b5-1 | -1,825 | $275.00 | $502k | 3,231 | Mar 26, 2025 |
Related signals
Other insiders at INSULET CORP and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 31Weak | PODDsell INSULET CORP | Luciana Borio director | $147k 481 shares | -13% | |
| 25Weak | INSULET CORP | Eric Benjamin EVP, CPXPO | $3.5M 12,394 shares | -52% | |
| 53Moderate | INSULET CORP | Eric Benjamin EVP, CPXPO | $1.2M 4,362 shares | -19% | |
| 41Moderate | INSULET CORP | Lauren Budden Group VP, CAO and Controller | $252k 915 shares | -14% | |
| 31Weak | PODDsell INSULET CORP | Luciana Borio director | $140k 508 shares | -15% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.